Problems with ascribing between-trial differences in BCG effectiveness to sensitization with environmental mycobacteria
Clin Infect Dis
.
2014 Aug 15;59(4):605-7.
doi: 10.1093/cid/ciu329.
Epub 2014 May 6.
Author
Douglas S Kernodle
1
Affiliation
1
Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine and Nashville Veterans Affairs Medical Center, Tennessee.
PMID:
24803374
DOI:
10.1093/cid/ciu329
No abstract available
Publication types
Letter
Comment
MeSH terms
BCG Vaccine / administration & dosage*
BCG Vaccine / immunology*
Humans
Tuberculosis, Meningeal / prevention & control*
Tuberculosis, Miliary / prevention & control*
Tuberculosis, Pulmonary / prevention & control*
Substances
BCG Vaccine